Portage Biotech Inc. (PRTG)
NASDAQ: PRTG · Real-Time Price · USD
7.36
-0.49 (-6.24%)
At close: Aug 27, 2025, 4:00 PM
7.02
-0.34 (-4.62%)
After-hours: Aug 27, 2025, 7:20 PM EDT
Portage Biotech Market Cap
Portage Biotech has a market cap or net worth of $16.77 million as of August 27, 2025. Its market cap has increased by 463.99% in one year.
Market Cap
16.77M
Enterprise Value
14.51M
1-Year Change
463.99%
Ranking
Category
Stock Price
$7.36
Market Cap Chart
Since June 5, 2013, Portage Biotech's market cap has decreased from $27.39M to $16.77M, a decrease of -38.77%. That is a compound annual growth rate of -3.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 27, 2025 | 16.77M | 189.36% |
| Dec 31, 2024 | 5.80M | -83.90% |
| Dec 29, 2023 | 36.00M | -60.12% |
| Dec 30, 2022 | 90.26M | -36.96% |
| Dec 31, 2021 | 143.18M | -39.51% |
| Dec 31, 2020 | 236.71M | 131.16% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 662.42B |
| Johnson & Johnson | 426.11B |
| AbbVie | 368.75B |
| UnitedHealth Group | 274.69B |
| AstraZeneca | 248.21B |
| Novartis AG | 243.97B |
| Novo Nordisk | 243.46B |
| Abbott Laboratories | 227.53B |